Avacincaptad pegol ophthalmic Interactions
No drug interactions were found for avacincaptad pegol ophthalmic. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Avacincaptad pegol ophthalmic is in the drug class anti-angiogenic ophthalmic agents. Avacincaptad pegol ophthalmic is used to treat the following conditions: Geographic Atrophy, Macular Degeneration.
Avacincaptad pegol ophthalmic disease interactions
There are 3 disease interactions with avacincaptad pegol ophthalmic which include:
Report options
QR code containing a link to this page
More about avacincaptad pegol ophthalmic
- avacincaptad pegol ophthalmic consumer information
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
